Showing 841-850 of 23043 results for "".
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
https://reachmd.com/programs/project-oncology/guideline-updates-anal-canal-squamous-cell-carcinoma/54280/As NCCN® Clinical Practice Guidelines in Oncology evolve, integrating chemoimmunotherapy into the management of advanced squamous cell carcinoma of the anal canal requires thoughtful, patient-centered decision-making. That’s why Dr. Stacey Cohen joins Dr. Charles Turck to translate updated recommendDon't Hesitate...Amputate! The Surgical Legacy of Robert Liston
https://reachmd.com/programs/rub-some-dirt-in-it/dont-hesitate-amputate-the-surgical-legacy-robert-liston/8261/Join us as we recall the high-speed surgical antics of 19th century Scottish surgeon Dr. Robert Liston, dubbed "The Fastest Knife in the West End."Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
https://reachmd.com/programs/project-oncology/large-cell-neuroendocrine-carcinoma-care-a-look-at-evolving-approaches/36460/Large cell neuroendocrine carcinoma is a rare, aggressive lung cancer often managed by adapting strategies from small cell and non-small cell lung cancers, starting with platinum-based chemotherapy and guided by molecular testing. As research expands, emerging options like KRAS G12C inhibitors, immuDo Celebrity Heart Attacks Influence Public Health?
https://reachmd.com/programs/lipid-luminations/do-celebrity-heart-attacks-influence-public-health/3569/Celebrities, often criticized for their dubious influence on the public, may inadvertently promote good health when a famous celebrity dies from a heart attack. Dr. James Erhlich discusses how the sudden death of a famous person heightens the general population’s interest in cardiovascuAssessing the Correlation Between Perianal Fistula Healing & Trough Levels of Infliximab in Children with IBD
https://reachmd.com/programs/Audioabstracts/assessing-the-correlation-between-perianal-fistula-healing-and-trough-levels-of-infliximab/10836/Some studies have found that IFX levels matter when treating fistulizing perianal Crohn’s Disease in adults, but is it the same case for children?FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
https://practicaldermatology.com/series/dermwire-tv/fda-approves-eli-lillys-ad-drug-ebglyss-lebrikizumab/28645/In this week's DermwireTV, Andrew F. Alexis, MD, Professor of Clinical Dermatology at Weill Cornell Medical College, discusses the newly approved AD drug lebrikizumab; LEO Pharma announces two major regulatory milestones for its chronic hand eczema (CHE) treatment; and the CMO of Arcutis BioteherapuShared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
https://reachmd.com/programs/project-oncology/shared-decision-making-squamous-cell-carcinoma-anal-canal/54281/Shared decision-making plays a critical role in managing squamous cell carcinoma of the anal canal, particularly as treatment options grow more complex and personalized. That’s why Dr. Brian McDonough sits down with Dr. Richard Kim to discuss practical strategies that can help align care with patienThe Angry Smile: Exploring the Psychological Impacts of Passive-Aggressive Behavior
https://reachmd.com/programs/primary-care-today/angry-smile-exploring-psychological-impacts-passive-aggressive-behavior/9712/Author Signe Whitson offers real-world examples and empowering, practical strategies for individuals confronted with passive aggressiveness.Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
https://reachmd.com/programs/global-neurology-academy/therapeutic-mechanism-action-moas-ms-targeting-t-and-b-cells-reset-immune-system/9533/This lecture was given live at Regional Medical Update Dinner on Current and Future Treatments educational program, which was held in select European cities. This highly-interactive live educational meeting will provide attendees with the most recent information concerning new and emerging treatmentManaging MCL After BTKi Failure: The Expanding Role of CAR T-Cell Therapy
https://reachmd.com/programs/project-oncology/managing-mcl-after-btki-failure-the-expanding-role-of-car-t-cell-therapy/35456/This is a non-certified educational series produced and controlled by ReachMD. For patients with mantle cell lymphoma (MCL) who relapse after BTK inhibitor (BTKi) therapy, treatment decisions can be complex and time sensitive. That’s why understanding how tumor biology and risk features can guide se